Inhibrx Biosciences, Inc.INBXNASDAQ
Loading
Income Tax Expense Over TimeStrong
Percentile Rank11
3Y CAGR-12.6%
5Y CAGR-7.8%
Studio
Year-over-Year Change

Income taxes paid or accrued

3Y CAGR
-12.6%/yr
vs -58.0%/yr prior
5Y CAGR
-7.8%/yr
Recent deceleration
Acceleration
+45.3pp
Accelerating
Percentile
P11
Within normal range
vs 5Y Ago
0.7x
Contraction
PeriodValueYoY Change
TTM$2000.000.0%
2024$2000.00-33.3%
2023$3000.000.0%
2022$3000.00+50.0%
2021$2000.00-33.3%
2020$3000.00-99.7%
2019$898000.00+835.4%
2018$96000.00-61.6%
2017$250000.00+105.4%
2016$-4.62M-